164 related articles for article (PubMed ID: 15849768)
1. Disseminated zygomycosis post allogeneic bone marrow transplantation.
Kannan K; Ur-Rehman J; Rao TV; Jain R; Dennison D
Am J Hematol; 2005 May; 79(1):68-9. PubMed ID: 15849768
[No Abstract] [Full Text] [Related]
2. Allogeneic bone marrow transplantation in children with ANL: Italian experience. AIEOP Group and the GITMO.
Dini G; Abla O; Uderzo C; Polchi P; Locatelli F; Di Bartolomeo P; Arcese W; Messina C; Bandini G; Andolina M
Bone Marrow Transplant; 1991; 7 Suppl 3():76-7. PubMed ID: 1855094
[No Abstract] [Full Text] [Related]
3. Eosinophilic folliculitis in a patient after allogeneic bone marrow transplantation: case report and review of the literature.
Ota M; Shimizu T; Hashino S; Shimizu H
Am J Hematol; 2004 Jul; 76(3):295-6. PubMed ID: 15224372
[TBL] [Abstract][Full Text] [Related]
4. Soft tissue sarcoma in the setting of chronic cutaneous graft versus host disease after allogenic bone marrow transplantation.
Bylund KC; Giampoli E; Singh D; Doerr T; Sahasrabudhe D; Liesveld J; Constine LS
Cancer Invest; 2008 Jul; 26(6):638-41. PubMed ID: 18584356
[TBL] [Abstract][Full Text] [Related]
5. Unexplained effusions: association with allogeneic bone marrow transplantation and acute or chronic graft-versus-host disease.
Pretnar J; Cernelc P; Mlakar U; Fortuna M
Bone Marrow Transplant; 1996 Oct; 18(4):826. PubMed ID: 8899209
[No Abstract] [Full Text] [Related]
6. Anti-leukemic effect of graft-versus-host disease on bone marrow and extramedullary relapses in acute leukemia.
Lee JH; Choi SJ; Lee JH; Seol M; Lee YS; Ryu SG; Park CJ; Chi HS; Lee MS; Yun S; Lee JS; Lee KH
Haematologica; 2005 Oct; 90(10):1380-8. PubMed ID: 16219575
[TBL] [Abstract][Full Text] [Related]
7. Rapamycin for Kaposi's sarcoma and graft-versus-host disease in bone marrow transplant recipient.
Marco de F; Infante B; Giovanni S; Gesualdo L
Transplantation; 2010 Mar; 89(5):633-4. PubMed ID: 20216371
[No Abstract] [Full Text] [Related]
8. Allogeneic and autologous bone marrow transplantation in AML.
Santos GW
Leukemia; 1992; 6 Suppl 2():102-3. PubMed ID: 1578906
[No Abstract] [Full Text] [Related]
9. Graft-versus-disease effect following allogeneic transplantation for acute leukaemia.
Rowe JM
Best Pract Res Clin Haematol; 2008 Sep; 21(3):485-502. PubMed ID: 18790451
[TBL] [Abstract][Full Text] [Related]
10. Failure of thalidomide to control bronchiolitis obliterans post bone marrow transplant.
Heaton DC
Bone Marrow Transplant; 1989 Sep; 4(5):598. PubMed ID: 2790340
[No Abstract] [Full Text] [Related]
11. Bone marrow transplantation for leukaemia: the role of total body irradiation, graft vs host disease, and haemopoietic chimerism.
Bacigalupo A; Frassoni F; Van Lint MT; Titale V; Scarpati D; Occhini D; Gualandi F; Lamparelli T; Marmont AM
Bone Marrow Transplant; 1989 Dec; 4 Suppl 3():85. PubMed ID: 2697412
[No Abstract] [Full Text] [Related]
12. Isolated testicular and bone relapse in children with acute myeloblastic leukemia and chronic graft versus host disease after allogeneic BMT.
Yildirim I; Uçkan D; Cetin M; Tuncer M; Tezcan I
Turk J Pediatr; 2007; 49(2):206-9. PubMed ID: 17907524
[TBL] [Abstract][Full Text] [Related]
13. Review of bone marrow transplants at the Ontario Cancer Institute.
Amato D; Bergsagel DE; Clarysse AM; Cowan DH; Iscove NN; McCulloch EA; Miller RG; Phillips RA; Ragab AH; Senn JS
Transplant Proc; 1971 Mar; 3(1):397-9. PubMed ID: 4398495
[No Abstract] [Full Text] [Related]
14. A second prophylactic MHC-mismatched bone marrow transplantation protects against rat acute myeloid leukemia (BNML) without lethal graft-versus-host disease.
Nestvold JM; Omdal BK; Dai KZ; Martens A; Benestad HB; Vaage JT; Rolstad B
Transplantation; 2008 Jan; 85(1):102-11. PubMed ID: 18192919
[TBL] [Abstract][Full Text] [Related]
15. Late appearance of an acute graft-vs.-host disease reaction subsequent to a graft-vs.-tumor effect induced by bone marrow transplantation in a refractory ovarian carcinoma patient.
Kawakami T; Takimoto M; Soma Y
Int J Dermatol; 2010 Mar; 49(3):308-10. PubMed ID: 20465671
[No Abstract] [Full Text] [Related]
16. Myasthenia gravis post allogeneic bone marrow transplantation revisited.
Koski SL; Mackey JR; Mackey DS
Bone Marrow Transplant; 1998 Aug; 22(4):403-4. PubMed ID: 9722080
[No Abstract] [Full Text] [Related]
17. Polyvisceral arteritis in chronic graft-versus-host disease: antiphospholipid-negative thrombotic syndrome mimicking polyarteritis nodosa.
Ysebaert L; Deconinck E; Larosa F; Caillot D; Tiberghien P; Casasnovas RO; Cahn JY
Bone Marrow Transplant; 2002 May; 29(10):873-4. PubMed ID: 12058239
[TBL] [Abstract][Full Text] [Related]
18. Two cases of hepatic zygomycosis in allogeneic stem cell transplant recipients and review of literature.
Padmanabhan S; Battiwalla M; Hahn T; Ball D; Paplham P; Brown K; Segal BH; McCarthy P; Almyroudis NG
Transpl Infect Dis; 2007 Jun; 9(2):148-52. PubMed ID: 17462002
[TBL] [Abstract][Full Text] [Related]
19. Generalized vitiligo after allogeneic bone marrow transplantation.
Cho SB; Roh MR; Chung KY; Lee KH; Park YK
Acta Derm Venereol; 2005; 85(1):82-3. PubMed ID: 15849005
[No Abstract] [Full Text] [Related]
20. Biopsy interpretation in bone marrow transplantation.
Snover DC
Pathol Annu; 1989; 24 Pt 2():63-101. PubMed ID: 2671885
[No Abstract] [Full Text] [Related]
[Next] [New Search]
